Intel & ValitaCell AI podcasts

There’s no point creating the future if you don’t tell anyone about it!

As part of the CELLIMAGE communications strategy, consortium members Intel and ValitaCell have recorded two podcasts on how Artificial Intelligence is revolutionising Biopharmaceutical and Cell Therapy Manufacturing.

In the first podcast, Building the Future of Labs, Project Director Paul Dobson and Intel’s Global Head of Lab & Life Sciences Sandra Colner recorded a fireside chat about where in biomanufacturing the opportunities lie for AI to make a difference.

In the second podcast, AI and Cell Therapy Intersect to Revolutionize the Biopharma Industry, ValitaCell’s Head of Science - Cell Therapy, Stephanie Davies and Sandra Colner spoke to host Tyler Kern about how CELLIMAGE’s new AI tools will revolutionise Cell Therapy Manufacturing to improve patient lives.